No Data
No Data
Monoclonal Antibodies in Veterinary Health, Global Market Outlook 2024-2033 With Analysis on Merck & Co, Zoetis, Elanco, Boehringer Ingelheim, Virbac, Invetx, Indian Immunologicals, and Others
Global Veterinary Vaccine Market 10 Year Analysis and Forecast 2023-2033, Featuring Key Player Profiles for Ceva Sante Animale, Elanco Animal Health, Merck, Zoetis, Phibro Animal Health and Virbac
Breakeven On The Horizon For Elanco Animal Health Incorporated (NYSE:ELAN)
Elanco Animal Health Incorporated (NYSE:ELAN) is possibly approaching a major achievement in its business, so we would like to shine some light on the company. Elanco Animal Health Incorporated, an a
Elanco Animal Health(ELAN.US) Director Buys US$50,493.73 in Common Stocks
$Elanco Animal Health(ELAN.US)$ Director Harrington Michael J purchased 3,100 shares of Common Stocks on Mar 8, 2024 at an average price of $16.2883 for a total value of $50,493.73.Source: Announcemen
Elanco Animal Health(ELAN.US) Director Buys US$244.5K in Common Stocks
$Elanco Animal Health(ELAN.US)$ Director DOYLE WILLIAM F purchased 15,000 shares of Common Stocks on Mar 8, 2024 at an average price of $16.3 for a total value of $244.5K.Source: Announcement What is
Elanco Stock Price Target Raised to $18 From $12 by Piper Sandler
On Tuesday, Piper Sandler modified its outlook on Elanco Animal Health (NYSE:NYSE:ELAN), raising the price target to $18.00 from the previous $12.00, while keeping a Neutral rating on the stock.
No Data